UnitedHealth Plans on Eliminating Out-Of-Pocket Costs for Some Drugs, Raises Financial Guidance

Starting as early as next year, UnitedHealth Group expects to have no co-pays or out-of-pocket costs for members in its UnitedHealthcare division’s standard fully insured group plans who take several medications, including insulins. The managed care organization made the announcement on July 15, coinciding with the release of the company’s second quarter financial results that beat Wall Street analyst expectations.

UnitedHealth increased its adjusted net earnings per share (EPS) guidance for the year to $21.40 to $21.90, up from its previous guidance of $21.20 to $21.70 issued during its first quarter earnings call in April.

0 Comments
© 2022 MMIT
Freelance Reporter

Freelance Reporter Freelance Reporter

Related Posts

unitedhealth-group-corporate-photo
April 21

UnitedHealth Delivers Strong 1Q, Touts MA, Value-Based Growth

READ MORE
unitedhealth-group-logo
April 15

UnitedHealth Sees Sunny 1Q, Says Deferred Care Impact Is MIA

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today